Has Harry Sukumaran, MD received payments from drug or device companies?

Yes. Drug and device makers reported $308,462 in general payments to Harry Sukumaran, MD across 771 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Harry Sukumaran, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Harry Sukumaran, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Harry Sukumaran, MD

Pain Medicine · Rochester Hills, MINPI 1356546709

Payments from drug & device makers

$308,462in general payments, 2019–2025

Across 771 payments — averaging $400.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Vertos Medical, Inc.$107K
SPR Therapeutics, Inc$71K
Stryker$31K
Boston Scientific$30K
Medtronic$19K
Si-bone, Inc.$16K
plus $35K from 32 others

$268in research payments, 2019–2025

Across 3 payments — averaging $89.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Saluda Medical Americas, Inc.$268

What the payments were for

Consulting fees$185,92861%
Speaking & faculty fees$50,76517%
Travel & lodging$34,41311%
Food & beverage$32,63611%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Vertos Medical, Inc.	151	$106,874
SPR Therapeutics, Inc	85	$70,916
Stryker	31	$30,778
Boston Scientific	58	$30,315
Medtronic(2 entities)	95	$19,492
Si-bone, Inc.	23	$15,504
Nevro Corp.	63	$11,800
Abbott	62	$4,770
Neuroone Medical Technologies Corporation	4	$4,431
Saluda Medical Americas, Inc.	14	$4,354
Spinal Simplicity, LLC	29	$2,453
MML US, Inc.	18	$1,382
Relievant Medsystems, Inc.	20	$1,368
Nalu Medical, Inc.	12	$856
Vertiflex, Inc.	13	$636
Collegium Pharmaceutical, Inc.	29	$519
Stimwave Technologies Incorporated	6	$459
Arthrex	3	$288
Curonix LLC	4	$194
Biotronik NRO, Inc.	4	$167
Pfizer	11	$145
Foundation Fusion Solutions, LLC	2	$137
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$130
Amgen	4	$91
ANI Pharmaceuticals, Inc.	3	$73
Virtus Pharmaceuticals LLC	3	$46
Pacira Therapeutics, Inc.	2	$41
Averitas Pharma Inc.	2	$41
Painteq LLC	1	$26
Sentynl Therapeutics, Inc.	2	$25
Scilex Pharmaceuticals Inc.	1	$24
Biodelivery Sciences International, Inc.	2	$23
Daiichi Sankyo Inc.	1	$22
AstraZeneca	1	$19
Fidia Pharma USA Inc.	1	$17
Assertio Therapeutics, Inc.	1	$16
Lilly USA, LLC	1	$15
GRT US Holding, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

mild Device Kit$143,410
SPRINT PNS System$68,819
SUPERION$18,007
IFUSE IMPLANT SYSTEM$14,991
INTELLIS ADAPTIVESTIM$14,546
Superion Indirect Decompression System$9,941
Omnia$9,373
SPINEJACK$4,616
Intracept$2,135
HA MINUTEMAN G3-R$1,948
Neuromodulation Dspsbls and Accs$1,505
INTELLIS$1,480
ReActiv8$1,068
GENERAL PAIN MANAGEMENT$1,015
Proclaim Family of SCS IPGs$881
PROCLAIM$829
Senza Spinal Cord Stimulation System$823
Nalu Neurostimulation System$528
Senza$393
Superion ISS$377

How this compares

$308,462 in reported general payments places this provider in the 95th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan →

Medicare billing

Part B allowed, 2024

$175,883

Medicare patients

195

Services billed

944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	14	$3,652
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	97	$1,669
Gabapentin	53	$660
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	49	$615
Pregabalin	19	$259
Oxycodone Hcl	18	$202
Morphine Sulfate ErMorphine Sulfate	12	$165
Duloxetine Hcl	13	$115
Tramadol Hcl	31	$78
Nortriptyline Hcl	11	$54
Meloxicam	17	$46
Cyclobenzaprine Hcl	12	$33

Paid to pharmacies, not to this prescriber.

Other pain medicine in Rochester Hills

Joel SaperAnn Arbor$5.7M
Bindu Popat LewisGrand Rapids$135K
Nasir KhatriFlint$133K
Yijia ChuGrand Rapids$88K
Mark MounayerSouthfield$85K
Jeffrey RosenbergCanton$72K
Alexander TurfeWyandotte$41K
Eric KozfkayWyoming$28K
Michael SikorskyBloomfield Hills$28K
Kendall GroseWyandotte$26K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →